MedTrace Logo

MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer Detection

NCT05901376 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 280

Last updated 2023-06-13

No results posted yet for this study

Summary

The goal of this observational study is to compare specific microRNA levels from the plasma of gastric cancer patients and healthy volunteers to see if there is an upregulated expression in gastric cancer patients.

The main question it aims to answer is:

\- Can microRNAs be effectively used as diagnostic biomarkers for gastric cancer?

Participants will be asked for their consent to obtain 5 cc of blood.

Conditions

Interventions

DIAGNOSTIC_TEST

MicroRNA

MiR-20a, MiR-21, MiR-106b, MiR-199a, MiR-223

Sponsors & Collaborators

  • King Chulalongkorn Memorial Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-25
Primary Completion
2025-01-31
Completion
2025-06-30

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05901376 on ClinicalTrials.gov